157 related articles for article (PubMed ID: 20574626)
1. Procalcitonin as a biomarker for toxic shock syndrome.
Kato M; Kaneko S; Takagaki K; Kohayagawa Y; Watanabe T; Yoshida Y; Yamamoto O
Acta Derm Venereol; 2010 Jul; 90(4):441-3. PubMed ID: 20574626
[No Abstract] [Full Text] [Related]
2. Procalcitonin-a new marker of severe infection and sepsis.
Reinhart K; Carlet J
Intensive Care Med; 2000 Mar; 26 Suppl 2():S145. PubMed ID: 18470708
[No Abstract] [Full Text] [Related]
3. An unusual case of progressive shock and highly elevated procalcitonin level.
Schumm J; Pfeifer R; Ferrari M; Kuethe F; Figulla HR
Am J Crit Care; 2010 Jan; 19(1):96-3. PubMed ID: 19304564
[TBL] [Abstract][Full Text] [Related]
4. Cytokine profile and T cell receptor analysis in a case of postpartum toxic shock syndrome.
Manabe K; Yamasaki O; Noda K; Katayama N; Tada K; Asagoe K
J Dermatol; 2017 Jan; 44(1):95-96. PubMed ID: 27154311
[No Abstract] [Full Text] [Related]
5. Toxic shock syndrome caused by hospital-acquired methicillin-resistant Staphylococcus aureus in a patient with pancytopenia.
Varghese B; Sanghavi R; Aziz A; Gosbell IB
Crit Care Resusc; 2010 Mar; 12(1):50-2. PubMed ID: 20196714
[TBL] [Abstract][Full Text] [Related]
6. [Procalcitonin--marker of infectious inflammation: clinical value and application].
Galstian GM; Gorodetskiĭ VM; Berkovskiĭ AL; Sergeeva EV; Speranskaia LL
Anesteziol Reanimatol; 2003; (2):26-31. PubMed ID: 12939938
[TBL] [Abstract][Full Text] [Related]
7. Axillary hydroadenitis; an unusual cause of toxic shock syndrome.
Ramón HJ; Ramírez-Rivera J
Bol Asoc Med P R; 2003; 95(6):7-10. PubMed ID: 15449785
[No Abstract] [Full Text] [Related]
8. Methicillin-resistant Staphylococcus aureus toxic shock syndrome.
Jamart S; Denis O; Deplano A; Tragas G; Vandergheynst A; De Bels D; Devriendt J
Emerg Infect Dis; 2005 Apr; 11(4):636-7. PubMed ID: 15834985
[No Abstract] [Full Text] [Related]
9. Postpartum toxic shock syndrome due to methicillin-resistant Staphylococcus aureus epidemic in community.
Collet C; Petsaris O; Lafforgue N; Poulain P; Gautier P; Michelet C; Donnio PY
Eur J Obstet Gynecol Reprod Biol; 2009 Jun; 144(2):184-5. PubMed ID: 19304364
[No Abstract] [Full Text] [Related]
10. Is plasma procalcitonin ready for prime time in the pediatric intensive care unit?
Mariscalco MM
Pediatr Crit Care Med; 2003 Jan; 4(1):118-9. PubMed ID: 12656558
[No Abstract] [Full Text] [Related]
11. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation.
Heyland DK; Johnson AP; Reynolds SC; Muscedere J
Crit Care Med; 2011 Jul; 39(7):1792-9. PubMed ID: 21358400
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of the semiquantitative procalcitonin test kit as a guideline for starting antibiotic administration.
Oh JS; Kim SU; Oh YM; Choe SM; Choe GH; Choe SP; Kim YM; Hong TY; Park KN
Am J Emerg Med; 2009 Sep; 27(7):859-63. PubMed ID: 19683118
[TBL] [Abstract][Full Text] [Related]
13. Procalcitonin levels predict identification of bacterial strains in blood cultures of septic patients: effect measures of association.
Ayubi E; Sani M
Am J Emerg Med; 2016 Dec; 34(12):2453-2454. PubMed ID: 27682516
[No Abstract] [Full Text] [Related]
14. Evidence of staphylococcal toxic shock syndrome caused by MRSA in a mother-newborn pair.
Rostad CA; Philipsborn RP; Berkowitz FE
Pediatr Infect Dis J; 2015 Apr; 34(4):450-2. PubMed ID: 25260039
[TBL] [Abstract][Full Text] [Related]
15. Lactate, procalcitonin, and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock.
Phua J; Koay ES; Lee KH
Shock; 2008 Mar; 29(3):328-33. PubMed ID: 18277855
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of endotoxin adsorption therapy (polymyxin B hemoperfusion) for methicillin-resistant Staphylococcus aureus toxic shock syndrome: a case report about five patients.
Taniguchi T; Sato K; Kurita A; Noda T; Okajima M
Minerva Anestesiol; 2013 Jul; 79(7):758-61. PubMed ID: 23635997
[TBL] [Abstract][Full Text] [Related]
17. [Determination of procalcitonin. Valuable for reducing ineffective antibiotic use is debatable].
Damoiseaux RA
Ned Tijdschr Geneeskd; 2009 Feb; 153(7):268-9. PubMed ID: 19291938
[No Abstract] [Full Text] [Related]
18. [Procalcitonin. A new marker for bacterial infection].
Casado Flores J; Blanco Quirós A
An Esp Pediatr; 2001 Jan; 54(1):69-73. PubMed ID: 11181198
[TBL] [Abstract][Full Text] [Related]
19. Procalcitonin-guided therapy in severe sepsis and septic shock. Authors' response.
Schlattmann P; Brunkhorst FM
Crit Care; 2014 May; 18(3):427. PubMed ID: 25473656
[No Abstract] [Full Text] [Related]
20. [Procalcitonin as a biomarker in infections].
Christ-Crain M
Praxis (Bern 1994); 2007 Jun; 96(25-26):1017-21. PubMed ID: 17639964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
